Table 3 Diagnostic performance of TSHR mRNA, serum Tg, and 131I uptake in identifying structural persistent disease
Diagnostic Performance (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
TSHR mRNAa | Serum Tgb | 131I whole body scan | |||||||
Total | TgAb-ve | TgAb + ve | Total | TgAb-ve | TgAb + ve | Total | TgAb-ve | TgAb + ve | |
Sensitivity | 62.3 | 53.8 | 88.2 | 79.7 | 90.4 | 47.1 | 46.4 | 42.3 | 58.8 |
Specificity | 42.9 | 42.9 | 42.9 | 81.6 | 81.6 | 81.6 | 87.8 | 87.8 | 87.8 |
PPVc | 60.6 | 50.0 | 34.9 | 85.9 | 83.9 | 47.1 | 84.2 | 78.6 | 62.5 |
NPVd | 44.7 | 46.7 | 91.3 | 74.1 | 88.9 | 81.6 | 53.8 | 58.9 | 86.0 |
Accuracy | 54.2 | 48.5 | 54.5 | 80.5 | 86.1 | 72.7 | 63.6 | 64.4 | 80.3 |